Cargando…
Hypermethylation of the Micro-RNA 145 Promoter Is the Key Regulator for NLRP3 Inflammasome-Induced Activation and Plaque Formation
Two major issues are involved in clinical atherosclerosis treatment. First, there are no significant clinical markers for early diagnosis of atherosclerosis. Second, the plaque will not regress once it initiates even if the risk factors are removed. In this paper, the research shows that the hyperme...
Autores principales: | Zhong, Wei, Li, Bo, Xu, Yao, Yang, Ping, Chen, Rui, Wang, Zhongqun, Shao, Chen, Song, Juan, Yan, Jinchuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6234615/ https://www.ncbi.nlm.nih.gov/pubmed/30456333 http://dx.doi.org/10.1016/j.jacbts.2018.06.004 |
Ejemplares similares
-
The Role of NLRP3 Inflammasome in Pericarditis: Potential for Therapeutic Approaches
por: Mauro, Adolfo G., et al.
Publicado: (2021) -
Sex-Specific Effects of the Nlrp3 Inflammasome on Atherogenesis in LDL Receptor-Deficient Mice
por: Chen, Shuang, et al.
Publicado: (2020) -
NLRP3 Inflammasome Inhibition: A Potential Therapeutic Strategy to Attenuate Postinfarction Adverse Cardiac Remodeling
por: Narendran, Siddharth, et al.
Publicado: (2020) -
Absence of NLRP3 Inflammasome in Hematopoietic Cells Reduces Adverse Remodeling After Experimental Myocardial Infarction
por: Louwe, Mieke C., et al.
Publicado: (2020) -
Promoter hypermethylation profiling of distant breast cancer metastases
por: Schrijver, Willemijne A. M. E., et al.
Publicado: (2015)